Logan Lutton

Teva’s Weltruza delivers olanzapine monthly under the skin, with no loading doses, oral supplementation or post-injection monitoring required.

In the CONNECT trial, CGM users with type 2 diabetes not on insulin saw larger A1C reductions and more time in range than those using finger-stick testing.

South Dakota voters rejected Amendment I, which could have ended Medicaid expansion for approximately 31,000 residents if federal funding fell below 90%.

The generic twice-yearly HIV prevention shot is expected to cost $40 a year in 120 countries, 16 months after Gilead's original approval.

Higher MRI-measured liver disease activity was linked to lower quality of life and more anxiety and activity problems in 802 adults with suspected MASLD/MASH in Europe.

Teen boys with obesity and lower baseline fitness were less likely to see MASLD resolve during a lifestyle program, a Belgian study found.

The FDA has approved three HIV products since June 2025, and the late-stage pipeline is testing how far apart doses can be spaced. Here are the milestones payers and health systems should track through 2027.

A review of 16 studies linked presurgical melatonin and zolpidem to less postoperative pain, with over 30% less opioid use in some patients.

Federal HIV guidelines add Bixlenvo as a switch option, back statins for adults 40 to 75 and urge clinicians to challenge payer barriers to antiretroviral therapy (ART).

Consistent bedtime routines, screen-free bedrooms and therapist support for night waking help children with ADHD sleep better, said Alison Pritchard, Ph.D.

Continuous glucose monitoring cut mean A1C from 8.8% to 7.2% over 26 weeks in adults with type 2 diabetes not on insulin, 0.9 points more than routine care in the CONNECT trial.

Apothecary Pharma is recalling 22 vials of compounded tirzepatide and one NAD+ vial nationwide, citing a lack of assurance of sterility.

Algia Pharma completed toxicology testing of AlgiaPak, a non-opioid regimen for mild-to-moderate acute pain and plans an Investigational New Drug (IND) application filing by the end of 2026.

On average, caregivers want to see their children with ADHD fall asleep 30 minutes faster, but the best sleep treatments average approximately 20 minutes, a new survey study found.

GLP-1 use in adults 65 and older with MASLD was linked to a 45% lower risk of death, and a 28% lower risk of hepatic decompensation, a new Houston Methodist Research Institute study shows.

All 46 people with HIV who started long-acting lenacapavir and cabotegravir at a University of California, San Francisco, clinic reached or kept viral suppression over a median of 100 weeks.

Vision impairment affected 17.6% of 1,484 adult burn survivors in a study presented at AAO 2026, with age the strongest predictor of difficulty seeing.

A two-year study of 53 glaucoma patients logged nearly 4,800 home VR visual field tests, yet no insurance code currently covers home perimetry.

Ahead of the Health System Executive Summit, Will Carroll, chief pharmacy officer at Sutter Health, shares the system’s pharmacy strategy, its approach to building a leadership pipeline and advice for pharmacy leaders seeking a stronger executive voice.

Rex Hoffman, M.D., MBA, chief medical officer of Providence Holy Cross Medical Center, discusses his transition from radiation oncologist to hospital executive and the panel discussion that led to his new book, “Difficult Dilemmas for Chief Medical Officers: 30 Case Studies.”

An ophthalmic imaging specialist outlined how lighting technique and serial documentation help clinicians tell normal iris pigment from disease.

Neuro-ophthalmologists reviewed migraine diagnosis, a stepwise treatment ladder and migraine mimics that often present first in eye clinics.

A session at AAO 2026 explained how Medicare, Medicare Advantage and commercial coverage policies differ in ophthalmology, and how practices can document and code to stay compliant

Presenters at AAO 2026 examined hospital eye coverage gaps, workforce strain and how ophthalmology can gain influence within health systems.

Price transparency data on 11 glaucoma surgery codes showed payer class was most consistently tied to price, with Medicaid and self-pay rates lowest.

The 2026 American Academy of Ophthalmology Meeting got started today in New Orleans with a mix of celebration and candor about the challenges facing ophthalmology today.

New guidelines for acute low back pain favors self-care, NSAIDs, physical therapy and acupuncture over routine imaging and first-line opioids.

Alison Pritchard, Ph.D., of Kennedy Krieger Institute, explains how ADHD and sleep problems reinforce each other in children and why clinicians should set clear expectations with caregivers before treatment begins.

In this interview, Melody Chang, RPh, BCOP, MBA, vice president of pharmacy operation at the American Oncology Network, discusses the network's pharmacy strategy and priorities.

In this discussion, Heather Burrell-Ward, M.D., provides an overview of her recent study that found TMS aimed at the default mode network improved processing speed in schizophrenia.